Neogen Chemicals
Specialty Chemicals · NEOGEN
Small CapBasic MaterialsHigh Growth
Haridas Kanani
Chairman and Managing Director · Pragmatic
Company DNA
Founder-Centric
About
Neogen Chemicals is a Small Cap company in the Basic Materials sector, listed on NSE as NEOGEN. With a market cap of ₹4K Cr and revenue of ₹758 Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. Strong promoter control and leadership by the Chairman and Managing Director, Haridas Kanani, drives strategic decision-making. Its strategic mandate: The specialty chemicals business necessitates high-value R&D investment to diversify its product portfolio and capture niche global market share.
FAQ
What kind of company is Neogen Chemicals?
Neogen Chemicals is a Small Cap Basic Materials company (NEOGEN) in the High Growth phase with a market cap of ₹4K Cr. It is classified as Founder-Centric in culture.
What is Neogen Chemicals's culture and work environment like?
Neogen Chemicals has a Founder-Centric culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. Strong promoter control and leadership by the Chairman and Managing Director, Haridas Kanani, drives strategic decision-making.
Who leads Neogen Chemicals?
Neogen Chemicals is led by Haridas Kanani (Chairman and Managing Director), a Pragmatic leader with 55 years of experience.
What are Neogen Chemicals's financials?
Neogen Chemicals reported revenue of ₹758 Cr in FY25 with a 5-year revenue CAGR of 16.8%. Operating margin: 14.4%. Market cap: ₹4K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
Strong promoter control and leadership by the Chairman and Managing Director, Haridas Kanani, drives strategic decision-making.
Mandate
The specialty chemicals business necessitates high-value R&D investment to diversify its product portfolio and capture niche global market share.
The specialty chemicals business necessitates high-value R&D investment to diversify its product portfolio and capture niche global market share.
Financials
Revenue FY25₹758 Cr
PAT FY25₹35 Cr
Rev CAGR 5Y16.8%
OPM14.4%
NPM4.6%
ROE4.4%
ROCE10.8%
P/E178.7
Fwd P/E58.4
P/B4.4
D/E141.5
Mkt Cap₹4K Cr
Promoter53.5%
Institutional27.1%
Similar Culture
Could You Lead Neogen Chemicals?
Take the Genome Benchmark →